0 %The rate of vertical transmission of both HIV and HHV-8 among the studied mother–child pairs was 0.0%.
GabonHHV-8 · VIH/sidapublished 2009Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 5 observations
Gold tier: mechanically validated evidence, with its primary source.
242 evidence items · page 4 / 10
0 %The rate of vertical transmission of both HIV and HHV-8 among the studied mother–child pairs was 0.0%.
GabonHHV-8 · VIH/sidapublished 2009Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 5 observations
79.5 %The qualitative adherence to antiretroviral therapy declared by patients was 79.5%.
GabonVIH/sidapublished 2019African journal of AIDS research : AJAReurope_pmcdocument of 6 observations
21.9 %The overall prevalence of HIV drug resistance was 21.9% among the study population in semi-rural Franceville, Gabon.
GabonVIH/sidapublished 2021The Journal of antimicrobial chemotherapyPubMeddocument of 7 observations
14.3 %Repeated seizures occurred in 14.3% of PLHIV with malaria.
Gabonpaludisme · VIH/sidaobserved 2021 to 2022published 2026PloS onePubMeddocument of 11 observations
0.6 ratioThe mean dN/dS ratio was 0.6 ± 0.3 in the (I, VF) subgroup.
GabonVIH/sidapublished 2020Journal of clinical medicine researchPubMeddocument of 4 observations
49 %Twenty-three national HIV testing service policies (49%) recommended retesting prior to antiretroviral treatment (ART) initiation.
GabonVIH/sidaobserved as of December 2021published 2023BMJ openPubMeddocument of 9 observations
12.5 %Among 16 sequenced HIV-1 samples, subtype G accounted for 12.5% of strains.
Gabonsubtype G · VIH/sidaobserved 2020–2021published 2023BMC infectious diseasesPubMeddocument of 8 observations
47 %Between 2016 and 2020, 47% of people living with HIV entered care in less than 28 days at two outpatient treatment centers in Libreville.
GabonVIH/sidaobserved 2016-2020published 2025Medecine tropicale et sante internationaleeurope_pmcdocument of 4 observations
0.9 %HIV strains in the studied population showed reduced susceptibility to nucleoside reverse transcriptase inhibitors in 0.9% of cases.
GabonVIH/sidapublished 2012BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/1471-2334-12-64
8.1 %Of 223 patients included in the study, 8.1% died.
GabonVIH/sidaobserved 2010–2012published 2015PloS onePubMeddocument of 5 observations
26.3 %Of 342 HIV drug resistance mutations detected in 84 PLHIV receiving ARVs in Gabon from 2019 to 2021, 26.3% were associated with protease inhibitors.
GabonVIH/sidaobserved 2019 to 2021published 2024BMC infectious diseasesPubMeddocument of 24 observations
0 casesNo case of chronic HEV infection was found among 762 adults infected with HIV-1 in Gabon.
Gabonchronic HEV infection · VIH/sidapublished 2017Medecine et sante tropicalesPubMeddocument of 8 observations
829 cells/μlThe mean number of CD4 T cells in absolute number was 829 ± 380 cells/μl by lay providers.
GabonVIH/sidapublished 2018Journal of immunological methodsPubMeddocument of 13 observations
29 %Of 103 participants, 30 of 102 (29%) were HIV positive.
GabonVIH/sidaobserved September 2024-January 2025published 2026IJID regionseurope_pmcdocument of 10 observations
36.9 %In Gabon in 2013, Staphylococcus aureus was detected in 36.9% of HIV patients and in 31.6% of healthy controls.
GabonVIH/sidaobserved 2013published 2015Frontiers in microbiologyPubMeddocument of 7 observations
85 %Among hospitalised PLHIV with tuberculosis, 85.0% were in the advanced HIV disease stage.
Gabontuberculose · VIH/sidaobserved 2021-2022published 2025Southern African journal of infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.4102/sajid.v40i1.695
10 samplesAmong 82 HIV-1-positive samples from Gabon, 10 (12.1%) had discordant subtypes between gag and env.
GabonVIH/sidapublished 2000JAIDS Journal of Acquired Immune Deficiency SyndromesOpenAlexdocument of 6 observations
25.5 %HPV-50'S prevalence among HIV-infected women in Ouagadougou was 25.5%.
GabonHPV-50'S · VIH/sidaobserved 2009–2010published 2011Acta tropicaeurope_pmcdocument of 8 observations
47.9 %Among hospitalised PLHIV with tuberculosis, 47.9% were on antiretroviral therapy.
Gabontuberculose · VIH/sidaobserved 2021-2022published 2025Southern African journal of infectious diseaseseurope_pmcdocument of 11 observationsDOI 10.4102/sajid.v40i1.695
30.4 %Of 342 HIV drug resistance mutations detected in 84 PLHIV receiving ARVs in Gabon from 2019 to 2021, 30.4% were associated with non-nucleoside reverse transcriptase inhibitors.
GabonVIH/sidaobserved 2019 to 2021published 2024BMC infectious diseasesPubMeddocument of 24 observations
75 %75% of HIV-negative pregnant women had at least one co-infection.
Gabonco-infection · VIH/sidapublished 2023Infectious diseases of povertyPubMeddocument of 7 observations
55.4 %Among 130 HIV-positive individuals aged 0–24 years in Gabon, 72 (55.4%) achieved viral suppression, defined as viral load < 1000 copies/mL.
GabonVIH/sidapublished 2026PathogensOpenAlexdocument of 6 observationsDOI 10.3390/pathogens15050502
4 patientsFour of the HIV-infected patients hospitalized for severe bullous toxicodermatosis had Lyell's syndrome.
GabonLyell's syndrome · severe bullous toxicodermatosis · VIH/sidapublished 1997PubMedOpenAlexdocument of 8 observations
65.6 %The sensitivity of Alere DETERMINE compared to the semi-automated ELISA Bio-Rad for HIV detection was 65.6%.
GabonVIH/sidapublished 2019Journal of clinical laboratory analysiseurope_pmcdocument of 4 observationsDOI 10.1002/jcla.22824
50 %Nearly half of the 62 HIV-2 patients had a body weight of more than 60 kg.
GabonVIH/sidaobserved 2003-2013published 2014Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.